WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹306 Cr | ₹276 Cr | ₹260 Cr | ₹232 Cr | ₹288 Cr |
What is the latest Net Current Assets ratio of WINDLAS BIOTECH ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹306 Cr |
| Mar2025 | ₹276 Cr |
| Mar2024 | ₹260 Cr |
| Mar2023 | ₹232 Cr |
| Mar2022 | ₹288 Cr |
How is Net Current Assets of WINDLAS BIOTECH Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹306 Cr | 10.85 | |
| Mar2025 | ₹276 Cr | 6.34 | |
| Mar2024 | ₹260 Cr | 11.73 | |
| Mar2023 | ₹232 Cr | -19.25 | |
| Mar2022 | ₹288 Cr | - | |
Compare Net Current Assets of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹2,102.6 Cr | -7% | -9.2% | 14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -7% |
-9.2% |
14.2% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses